Stéphanie Lacomme
-
- Thyroid Cancer Diagnosis and Treatment 2
-
- Effects and risks of endocrine disrupting chemicals 2
-
- Neurofibromatosis and Schwannoma Cases 3
-
- Meningioma and schwannoma management 3
-
- Retinoids in leukemia and cellular processes 3
-
- Lung Cancer Diagnosis and Treatment 3
- Lung Cancer Treatments and Mutations 3
-
- Radiomics and Machine Learning in Medical Imaging 2
Stéphanie Lacomme
19 papers receiving 358 citations
Peers
Comparison fields: 5 of 63
- Cancer Research 80
- Endocrinology, Diabetes and Metabolism 71
- Genetics 45
- Health, Toxicology and Mutagenesis 36
- Neurology 34
Countries citing papers authored by Stéphanie Lacomme
This map shows the geographic impact of Stéphanie Lacomme's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Stéphanie Lacomme with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Stéphanie Lacomme more than expected).
Fields of papers citing papers by Stéphanie Lacomme
This network shows the impact of papers produced by Stéphanie Lacomme. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Stéphanie Lacomme. The network helps show where Stéphanie Lacomme may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Stéphanie Lacomme, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2024 | 1 | |
| 3 | 2024 | 3 | |
| 4 | 2023 | 3 | |
| 5 | 2022 | 6 | |
| 6 | 2022 | 6 | |
| 7 | 2021 | 8 | |
| 8 | 2020 | 43 | |
| 9 | 2019 | 0 | |
| 10 | 2019 | 24 | |
| 11 | 2018 | 2 | |
| 12 | 2017 | 14 | |
| 13 | 2015 | 55 | |
| 14 | 2013 | 15 | |
| 15 | 2011 | 49 | |
| 16 | 2009 | 4 | |
| 17 | 2009 | 8 | |
| 18 | 2009 | 8 | |
| 19 | 2009 | 20 | |
| 20 | 2007 | 70 |
About Stéphanie Lacomme
Stéphanie Lacomme is a scholar working on Cancer Research, Neurology and Endocrinology, Diabetes and Metabolism, having authored 21 papers that have together received 367 indexed citations. Recurring topics across this work include Meningioma and schwannoma management (3 papers), Retinoids in leukemia and cellular processes (3 papers), Lung Cancer Diagnosis and Treatment (3 papers), Neurofibromatosis and Schwannoma Cases (3 papers), Lung Cancer Treatments and Mutations (3 papers), Radiomics and Machine Learning in Medical Imaging (2 papers), Thyroid Cancer Diagnosis and Treatment (2 papers) and Effects and risks of endocrine disrupting chemicals (2 papers). The work is most often cited by research in Cancer Research (80 citations), Endocrinology, Diabetes and Metabolism (71 citations) and Genetics (45 citations). Stéphanie Lacomme has collaborated with scholars based in France, Greece and Germany. Frequent co-authors include D Belpomme, Philippe Irigaray, Guillaume Gauchotte, J.A. Newby, Jean-Michel Vignaud, Shyue-Fang Battaglia-Hsu, Jean‐Louis Guéant, Amandine Luc, Celso Pouget and Christophe Paris. Their work appears in journals such as The FASEB Journal, International Journal of Molecular Sciences and Cancer Letters.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.